Table 2.
Outcome of interest | No. of | No. of | Effects | SMD | 95% CI | Heterogeneity | P-value | |||
---|---|---|---|---|---|---|---|---|---|---|
study | patients | model | P value | I 2 (%) | ||||||
arms | ||||||||||
TC | 6 | 436 | Random | −0.375 | −0.757 to 0.006 | 0.002 | 73.80 | 0.054 | ||
Form of intervention | Turmeric powder | 2 | 186 | Fixed | −0.000 | −0.288 to 0.288 | 0.272 | 17.10 | 0.999 | |
Turmeric extract | 2 | 103 | Fixed | −0.584 | −0.980 to −0.188 | 0.228 | 31.10 | 0.004* | ||
Type of disease | MetS | 2 | 136 | Fixed | −0.934 | −1.289 to −0.579 | 0.510 | 0.000 | <0.0001*** | |
Hyperglycemia | 4 | 300 | Fixed | −0.059 | −0.285 to 0.168 | 0.561 | 0.000 | 0.612 |
MetS metabolic syndrome
*p < 0.05
**p < 0.001
***p < 0.0001